Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Journal of Drug Targeting|April 13, 2006
Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes)Frederik Tack, Annette Bakker, Sophie Maes, et al.Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.American Journal of Medical Genetics. Part A|March 26, 2019
From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and SchwannomatosisRosalie E Ferner, Annette Bakker, Ype Elgersma, et al.European Journal of Medicinal Chemistry|April 8, 2015
Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathwayArianna Nencini, Carmela Pratelli, Joanna M Quinn, et al.American Journal of Medical Genetics. Part A|April 25, 2017
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosisJaishri O Blakeley, Annette Bakker, Anne Barker, et al.Molecular Cancer Therapeutics|April 27, 2013
Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cellsAlessandra De Robertis, Silvia Valensin, Marco Rossi, et al.Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.American Journal of Medical Genetics. Part A|April 23, 2015
The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approachBruce Korf, Reza Ahmadian, Judith Allanson, et al.American Journal of Medical Genetics. Part A|April 23, 2018
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosisMichael J Fisher, Allan J Belzberg, Peter de Blank, et al.American Journal of Medical Genetics. Part A|May 8, 2016
The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathwayDavid A Stevenson, Lisa Schill, Lisa Schoyer, et al.Pageof 4